Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy
Author(s) -
Gaia Nebbia,
Caroline Sabin,
David Dunn,
Anna María Geretti
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm067
Subject(s) - nucleoside reverse transcriptase inhibitor , reverse transcriptase , reverse transcriptase inhibitor , virology , human immunodeficiency virus (hiv) , mutation , medicine , nucleoside , didanosine , antiretroviral therapy , zidovudine , biology , viral disease , genetics , viral load , rna , gene
The aim of the study was to determine whether mutations at RT codon 208 are associated with nucleoside RT inhibitor (NRTI) exposure, NRTI resistance patterns and HIV-1 subtype.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom